Interactions between circulating nanoengineered polymer particles and extracellular matrix components in vitro
Source abstract
Abstract
The extracellular matrix (ECM) that surrounds cells in vivo represents a biological barrier for nanomaterials in biomedicine. Herein, we present a system for investigating the interactions between circulating polymer particles and ECM components in vitro using a commercially available flow-based device. We use this system to show how material-dependent interactions of two different particle types-one assembled using poly(ethylene glycol) (PEG) and one prepared using poly(methacrylic acid) (PMA)-affect their interactions with basement membrane extracts during in vitro circulation, with PEG particles remaining in circulation longer than PMA particles. Further, by comparing macroporous hyaluronic acid gel constructs (typically used for tissue engineering) with basement membrane extracts, we show that scaffold-effects (porosity and surface chemistry) impact on circulation time in vitro. The presented system is simple and modular, and can be used to rapidly screen fundamental interactions of engineered particles with biologically relevant microenvironments under flow-conditions.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
and the Department of Chemical and Biomolecular Engineering
The University of Melbourne
Parkville
Australia
Department of Chemical and Biomolecular Engineering
Funding
Australian Research Council
References (56)
Show source-provided references
1. Elsabahy · Chem. Rev. · 2015 · 115 · 1096710.1021/acs.chemrev.5b00135 ↗
2. Irvine · Chem. Rev. · 2015 · 115 · 1110910.1021/acs.chemrev.5b00109 ↗
3. Gaitzsch · Chem. Rev. · 2016 · 116 · 105310.1021/acs.chemrev.5b00241 ↗
4. Cui · Acc. Chem. Res. · 2016 · 49 · 113910.1021/acs.accounts.6b00088 ↗
5. Blanco · Nat. Biotechnol. · 2015 · 33 · 94110.1038/nbt.3330 ↗
6. Wilhelm · Nat. Rev. Mater. · 2016 · 1 · 1601410.1038/natrevmats.2016.14 ↗
7. Tibbitt · J. Am. Chem. Soc. · 2016 · 138 · 70410.1021/jacs.5b09974 ↗
8. Yan · Chem. Mater. · 2014 · 26 · 45210.1021/cm402126n ↗
9. Nel · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
10. Kanapathipillai · Adv. Drug Delivery Rev. · 2014 · 79–80 · 10710.1016/j.addr.2014.05.005 ↗
11. Petros · Nat. Rev. Drug Discovery · 2010 · 9 · 61510.1038/nrd2591 ↗
12. Albanese · Annu. Rev. Biomed. Eng. · 2012 · 14 · 110.1146/annurev-bioeng-071811-150124 ↗
13. Cheng · Nat. Rev. Drug Discovery · 2015 · 14 · 23910.1038/nrd4503 ↗
14. Chauhan · Nat. Mater. · 2013 · 12 · 95810.1038/nmat3792 ↗
15. Torchilin · Adv. Drug Delivery Rev. · 2011 · 63 · 13110.1016/j.addr.2010.03.011 ↗
16. Maeda · Adv. Drug Delivery Rev. · 2015 · 91 · 310.1016/j.addr.2015.01.002 ↗
17. Curry · Nat. Nanotechnol. · 2016 · 11 · 49410.1038/nnano.2016.21 ↗
18. Matsumoto · Nat. Nanotechnol. · 2016 · 11 · 53310.1038/nnano.2015.342 ↗
19. Kalluri · Nat. Rev. Cancer · 2003 · 3 · 42210.1038/nrc1094 ↗
20. Mouw · Nat. Rev. Mol. Cell Biol. · 2014 · 15 · 77110.1038/nrm3902 ↗
21. Baluk · Am. J. Pathol. · 2003 · 163 · 180110.1016/S0002-9440(10)63540-7 ↗
22. Netti · Cancer Res. · 2000 · 60 · 2497
23. Ramanujan · Biophys. J. · 2002 · 83 · 165010.1016/S0006-3495(02)73933-7 ↗
24. Yokoi · Cancer Res. · 2014 · 74 · 423910.1158/0008-5472.CAN-13-3494 ↗
25. Lieleg · Biophys. J. · 2009 · 97 · 156910.1016/j.bpj.2009.07.009 ↗
26. Arends · Langmuir · 2013 · 29 · 1596510.1021/la404016y ↗
27. Huo · Cancer Res. · 2013 · 73 · 31910.1158/0008-5472.CAN-12-2071 ↗
28. Huang · ACS Nano · 2012 · 6 · 448310.1021/nn301282m ↗
29. Agarwal · Adv. Healthcare Mater. · 2015 · 4 · 226910.1002/adhm.201500441 ↗
30. Valencia · Nat. Nanotechnol. · 2012 · 7 · 62310.1038/nnano.2012.168 ↗
31. Björnmalm · J. Controlled Release · 2014 · 190 · 13910.1016/j.jconrel.2014.04.030 ↗
32. Swartz · Annu. Rev. Biomed. Eng. · 2007 · 9 · 22910.1146/annurev.bioeng.9.060906.151850 ↗
33. Albanese · Nat. Commun. · 2013 · 4 · 271810.1038/ncomms3718 ↗
34. Raeesi · Nanoscale · 2016 · 8 · 1252410.1039/C5NR08463F ↗
35. Henderson · J. Biomater. Sci., Polym. Ed. · 2015 · 26 · 88110.1080/09205063.2015.1065597 ↗
36. Henderson · J. Mater. Chem. B · 2013 · 1 · 268210.1039/c3tb20280a ↗
37. Björnmalm · Chem. Mater. · 201610.1021/acs.chemmater.6b02848 ↗
38. Cui · Adv. Mater. · 2014 · 26 · 729510.1002/adma.201402753 ↗
39. Cui · ACS Nano · 2015 · 9 · 157110.1021/nn5061578 ↗
40. Cui · Adv. Mater. · 2013 · 25 · 346810.1002/adma.201300981 ↗
41. Best · Langmuir · 2013 · 29 · 982410.1021/la402146t ↗
42. Cui · Langmuir · 2016 · 32 · 1239410.1021/acs.langmuir.6b01634 ↗
43. Arends · PLoS One · 2015 · 10 · e011809010.1371/journal.pone.0118090 ↗
44. Richardson · Nanoscale · 2014 · 6 · 1341610.1039/C4NR04348K ↗
45. Riches · J. Physiol. · 1973 · 228 · 27910.1113/jphysiol.1973.sp010086 ↗
46. Yan · Adv. Mater. · 2011 · 23 · 391610.1002/adma.201101609 ↗
47. Kleinman · Biochemistry · 1982 · 21 · 618810.1021/bi00267a025 ↗
48. Kleinman · Biochemistry · 1986 · 25 · 31210.1021/bi00350a005 ↗
49. Kleinman · Semin. Cancer Biol. · 2005 · 15 · 37810.1016/j.semcancer.2005.05.004 ↗
50. Van Beek · Biomaterials · 2008 · 29 · 78010.1016/j.biomaterials.2007.10.039 ↗
51. Kogan · Biotechnol. Lett. · 2006 · 29 · 1710.1007/s10529-006-9219-z ↗
52. Geng · Nat. Nanotechnol. · 2007 · 2 · 24910.1038/nnano.2007.70 ↗
53. Björnmalm · Langmuir · 2016 · 32 · 1099510.1021/acs.langmuir.6b03216 ↗
54. Björnmalm · J. Am. Chem. Soc. · 2016 · 138 · 1344910.1021/jacs.6b08673 ↗
55. Bhatia · Nat. Biotechnol. · 2014 · 32 · 76010.1038/nbt.2989 ↗
56. Esch · Nat. Rev. Drug Discovery · 2015 · 14 · 24810.1038/nrd4539 ↗